US growth, injectable iron pipeline: How AFT Pharma is driving toward $300 million by FY27
AFT Pharmaceuticals (ASX:AFP) is in a red-hot position as we head straight into FY26’s fourth quarter in Australia, and founder and managing director Hartley Atkinson believes it’s only going to get better as the growing Oz-based multinational pharmaceutical compan...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| TEM | Ann: Net Asset Value(s) | 06:50 | 0 | 3 | |||
|
|||||||
| TEM | Ann: Net Asset Value(s) | 14/04/26 | 0 | 11 | |||
|
|||||||
| TEM | Ann: Transaction in Own Shares | 14/04/26 | 0 | 11 | |||
|
|||||||
| TEM | Ann: Net Asset Value(s) | 13/04/26 | 0 | 9 | |||
|
|||||||
| TEM | Ann: Transaction in Own Shares | 13/04/26 | 0 | 12 | |||
|
|||||||
| TEM | Ann: Net Asset Value(s) | 10/04/26 | 0 | 27 | |||
|
|||||||
| TEM | Ann: Transaction in Own Shares | 10/04/26 | 0 | 26 | |||
|
|||||||
| TEM | Ann: Net Asset Value(s) | 09/04/26 | 0 | 20 | |||
|
|||||||
See All Discussions
NZX News